Feature Channels:

Dermatology

Add to Favorites Subscribe Share
fbshare-Dermatology

Showing results

110 of 1112
  • Embargo expired:
    17-Oct-2019 1:05 AM EDT

Article ID: 720620

New Effective Vaccines for Lyme Disease are Coming

Rutgers University-New Brunswick

A new paper published in the October 17 2019 issue of Clinical Infectious Diseases reiterates the need to stop the infection and defines a strategy for developing effective vaccines.

Released:
11-Oct-2019 2:30 PM EDT
Embargo will expire:
21-Oct-2019 11:00 AM EDT
Released to reporters:
15-Oct-2019 4:20 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 21-Oct-2019 11:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Painless Tape Strips Used to Detect Molecular Changes in Skin of Children with Eczema

Article ID: 720756

Painless Tape Strips Used to Detect Molecular Changes in Skin of Children with Eczema

Ann and Robert H. Lurie Children's Hospital of Chicago

In a study using non-invasive tape strips in young children with eczema (or atopic dermatitis), researchers found many molecular signs of immune dysfunction and skin changes that relate to disease activity. These signs (or biomarkers) were present even before eczema was visible and can be used to track disease activity over time. With more research, these biomarkers also may help predict response to medicine and development of conditions associated with eczema, such as asthma, other allergies, infections and even attention deficit hyperactivity disorder (ADHD). Findings were published in JAMA Dermatology.

Released:
15-Oct-2019 10:05 AM EDT
Newswise: Nearly $40,000 Raised for Skin Cancer Prevention and Detection Through “Skin Cancer, Take a Hike!™”

Article ID: 720681

Nearly $40,000 Raised for Skin Cancer Prevention and Detection Through “Skin Cancer, Take a Hike!™”

American Academy of Dermatology

This fall, a group of skin cancer advocates and their families and friends in both Chicago and Phoenix hiked three miles to say “Skin Cancer, Take a Hike!” Together, they raised nearly $40,000 for SPOT Skin Cancer™ benefiting the American Academy of Dermatology’s skin cancer prevention and detection programs, including free skin cancer screenings, sunscreen dispensers, and permanent shade structures in outdoor spaces where children learn and play.

Released:
14-Oct-2019 11:05 AM EDT

Article ID: 720595

New Test Diagnoses Lyme Disease within 15 Minutes

Columbia University School of Engineering and Applied Science

Current testing for Lyme disease, called the standard 2-tiered approach or the STT, involves running two complex assays (ELISA and western blot) to detect antibodies against the bacterium, and requires experienced personnel in a lab, and a few hours to carry out and interpret. Columbia biomedical engineers have developed a rapid microfluidic test that can detect Lyme disease with similar performance as the STT in a much shorter time—15 minutes.

Released:
11-Oct-2019 11:30 AM EDT
uclahealthlogo.gif
  • Embargo expired:
    11-Oct-2019 11:00 AM EDT

Article ID: 720348

Expert second opinion improves reliability of melanoma diagnoses

University of California, Los Angeles (UCLA), Health Sciences

A new study led by UCLA researchers, have found that obtaining a second opinion from pathologists who are board certified or have fellowship training in dermatopathology can help improve the accuracy and reliability of diagnosing melanoma, one of the deadliest and most aggressive forms of skin cancer.

Released:
8-Oct-2019 1:05 PM EDT

Article ID: 720513

How to Treat Eczema in Babies

American Academy of Dermatology

Atopic dermatitis (also known as eczema) is a common skin condition in babies. It affects up to 25% of children, and an estimated 60% of people with eczema develop it during their first year of life. While there is no cure, dermatologists from the American Academy of Dermatology say most cases can be controlled with a customized skin care plan, which may include moisturizers, prescription medications and strategies to eliminate triggers.

Released:
11-Oct-2019 7:40 AM EDT

Article ID: 720442

Absorption Systems Awarded 5-year IDIQ Contract by the U.S. Food and Drug Administration

Absorption Systems

To conduct preclinical testing of locally-acting topical dermal and ophthalmic drug product formulations

Released:
9-Oct-2019 10:05 AM EDT

Announcement

Channels:

Dermatology,

Languages:

English

logoMOFFITT_2c_RGB.jpg

Article ID: 720364

Melanoma Variability at the Single-Cell Level Predicts Treatment Responses, Say Moffitt Researchers

Moffitt Cancer Center

In a new study published in EBioMedicine, researchers with Moffitt Cancer Center’s Donald A. Adam Melanoma and Skin Cancer Center of Excellence reveal that differences at the single-cell level can predict responses to initial BRAF inhibitor therapy, and that leveraging these differences may improve patient outcomes.

Released:
8-Oct-2019 10:30 AM EDT

Showing results

110 of 1112

Chat now!